Search Results - "Patruni, Sunita"

Postsymptomatic restoration of SMN rescues the disease phenotype in a mouse model of severe spinal muscular atrophy by Lutz, Cathleen M, Kariya, Shingo, Patruni, Sunita, Osborne, Melissa A, Liu, Don, Henderson, Christopher E, Li, Darrick K, Pellizzoni, Livio, Rojas, José, Valenzuela, David M, Murphy, Andrew J, Winberg, Margaret L, Monani, Umrao R

“…Spinal muscular atrophy (SMA) is a common neuromuscular disorder in humans. In fact, it is the most frequently inherited cause of infant mortality, being the…”
Get full text

Aggressive Disease and Rare Sequelae in a Unique Case of Atypical Hemolytic Uremic Syndrome Secondary to Adult Onset Still’s Disease by Khattab, Ahmed, Yellala, Amulya, Mamadgi, Jyothika, Patruni, Sunita, Kaplan, Robert

Get full text

Socioeconomic disparities causing delays in pancreatic cancer germline genetic testing by Zou, Xianghui, King, Daniel, Sidiqi, Baho, Patruni, Sunita, Hollweg, Christopher, Kauff, Noah D.

“…665 Background: Germline genetic testing is recommended for patients with pancreatic ductal adenocarcinoma (PDAC) and pre-diagnostic testing is offered to…”
Get full text

Pancreatic cancer germline mutation report: An in-depth analysis of demographics, mutation profile, and patient survival by Zou, Xianghui, Sidiqi, Baho, Patruni, Sunita, Hollweg, Christopher, Kauff, Noah D., King, Daniel

“…e16233 Background: Germline genetic testing is now recommended for patients with pancreatic ductal adenocarcinoma (PDAC). We explored whether attributes of…”
Get full text

Socioeconomic and demographic barriers associated with delays in pancreatic cancer germline genetic testing by Zou, Xianghui, Sidiqi, Baho, Tortorella, Brooke, Patruni, Sunita, Rezak, Leora, Alfano, Catherine M., Hollweg, Christopher, Kauff, Noah D., King, Daniel

“…e18506 Background: Germline genetic testing is recommended for patients with pancreatic ductal adenocarcinoma (PDAC). We identified associations between…”
Get full text

Hematological Complications of Donor Origin Following Allogeneic Hematopoietic Stem Cell Transplantation by Khattab, Ahmed, Patruni, Sunita, Berteotti, Gina, Jayakrishnan, Thejus, Fazal, Salman, Lister, John

“…Allogeneic hematopoietic stem cell transplant (HSCT) offers curative therapy for some malignant hematological disease and marrow failure states…”
Get full text

Effect of neoadjuvant therapy pathway (NATP) for pancreatic cancer on overall patient outcomes by Cooper, Dylan, Sidiqi, Baho, Parakrama, Ruwan, Demyan, Lyudmyla, Pasha, Shamsher, Pinto, Danielle, Zavadsky, Tiffany, Zou, Xianghui, Patruni, Sunita, Kapusta, Adrianna, Standring, Oliver, Nosrati, Jason, Tchelebi, Leila T, Weiss, Matthew John, Herman, Joseph M., King, Daniel

“…695 Background: Significant variation exists in the management of potentially resectable pancreatic ductal adenocarcinoma (PDAC) across healthcare systems. We…”
Get full text

Lipid and neutrophil accumulation and active inflammasome in high BMI tumor regions of human pancreatic ductal adenocarcinoma by Khattab, Ahmed, Patruni, Sunita, Garciafigueroa, Yesica, Phillips, Brett, Engman, Carl, Khatoon, Nazia, Shankar, Karthik, Rizvi, Ali, Miller, Stacey, Zheng, Lei, Giannoukakis, Nick, Monga, Dulabh K.

“…Abstract only e16271 Background: Obesity is an established risk factor for cancer and cancer-related mortality. Adipocytes may act as a “damage” signal…”
Get full text

Significant lipid and neutrophil accumulation and active inflammasome in high BMI tumor regions of human pancreatic ductal adenocarcinoma by Khattab, Ahmed, Patruni, Sunita, Garciafigueroa, Yesica, Phillips, Brett, Engman, Carl, Khatoon, Nazia, Shankar, Karthik, Rizvi, Ali, Miller, Stacey, Giannoukakis, Nick, Monga, Dulabh K.

“…Abstract only 438 Background: Obesity is an established risk factor for cancer and cancer-related mortality. Adipocytes may act as a “damage” signal resulting…”
Get full text

Immunotherapy in the Management of Esophagogastric Cancer: A Practical Review by Patruni, Sunita, Fayyaz, Fatima, Bien, Jeffrey, Phillip, Tony, King, Daniel A

“…Recent data support incorporation of immune checkpoint inhibitors into the treatment armamentarium for esophageal, gastroesophageal junction, and gastric…”
Get more information

Retrospective analysis of outcomes in patients with non metastatic cholangiocarcinoma: A single network experience by Mamadgi, Jyothika, Lundeen, Kristina, Hasan, Shaakir, Patruni, Sunita, Khattab, Ahmed, Yellala, Amulya, Kirichenko, Alexander V., Raj, Moses S.

“…Abstract only e15643 Background: Biliary tract cancers are rare cancers with an annual incidence of about 8,000. In resected non-metastatic BTCs (NM-BTCs),…”
Get full text

Treatment response and survival in patients with pancreatic adenocarcinoma receiving neoadjuvant chemotherapy or chemoradiation by Khattab, Ahmed, Patruni, Sunita, Abel, Stephen, Hasan, Shaakir, Finley, Gene Grant, Monga, Dulabh K., Wegner, Rodney E, Verma, Vivek

“…Abstract only e15715 Background: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy with a poor prognosis. Neoadjuvant chemotherapy (NeoChT)…”
Get full text

Donor Cell Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation by Khattab, Ahmed, Patruni, Sunita, Patrus, Gina, Samhouri, Yazan, Fazal, Salman, Lister, John

“…Approximately 25,000 allogeneic transplants are performed annually worldwide; a figure that has steadily increased over the past three decades. The study of…”
Get full text

Significant neutrophil accumulation, IL-18 deposition, and active inflammasome in tumor regions of human pancreatic ductal adenocarcinoma by Khattab, Ahmed, Garciafigueroa, Yesica, Phillips, Brett, Patruni, Sunita, Kamran, Amir, Jayakrishnan, Thejus, Khatoon, Nazia, Mohy-ud-din, Nabeeha, Monga, Satdarshan P, Miller, Stacey, Giannoukakis, Nick, Monga, Dulabh K.

“…Abstract only e15754 Background: Obesity is an established risk factor for cancer and cancer-related mortality. Adipocytes may act as a “damage” signal…”
Get full text

A comparative analysis of survival in patients with non-small cell lung cancer with brain metastases receiving intracranial radiation with and without immunotherapy by Patruni, Sunita, Khattab, Ahmed, Abel, Stephen, Hasan, Shaakir, Rizwan, Saleha, Finley, Gene Grant, Monga, Dulabh K., Verma, Vivek, Wegner, Rodney E

“…Abstract only 9025 Background: Many patients diagnosed with advanced non-small cell lung cancer (NSCLC) will develop intracranial metastasis, contributing…”
Get full text

Rare presentation of cryptococcal meningitis in an immunocompetent patient by Khattab, Ahmed, Patruni, Sunita, Sealey, Mary L

“…Cryptococcal meningitis is an opportunistic infection predominantly affecting immunocompromised patients but rarely can affect the immunocompetent. We describe…”
Get full text

Abstract PR001: Socioeconomic analysis and disparities in germline genetic testing for pancreatic cancer by Zou, Xianghui, Sidiqi, Baho, Patruni, Sunita, Hollweg, Christopher, Kauff, Noah, King, Daniel

“…Introduction: Germline genetic testing is now recommended for patients with pancreatic ductal adenocarcinoma (PDAC). We explored whether attributes of testing,…”
Get full text

Aggressive Disease and Rare Sequelae in a Unique Case of Atypical Hemolytic Uremic Syndrome Secondary to Adult Onset Still's Disease by Khattab, Ahmed, Yellala, Amulya, Mamadgi, Jyothika, Patruni, Sunita, Kaplan, Robert

“…Atypical hemolytic uremic syndrome (aHUS) is a rare form of thrombotic microangiopathy (TMA) which generally presents as a triad of thrombocytopenia, hemolytic…”
Get full text

Abstract A022: Standardization of a neoadjuvant therapy (NAT) pathway for pancreatic cancer across a geographically large and diverse healthcare system improves patient outcomes and successful completion of NAT by Parakrama, Ruwan, Sidiqi, Baho, Demyan, Lyudmyla, Pasha, Shamsher, Pinto, Danielle, Zavadsky, Tiffany, Zhou, Xianghui, Patruni, Sunita, Kapusta, Adrianna, Standring, Oliver, Weiss, Matthew J., Herman, Joseph M., King, Daniel A.

“…Optimal management of patients with potentially resectable pancreatic ductal adenocarcinoma (PDAC) is controversial and variation exists within/across academic…”
Get full text

Long-term outcomes by response to neoadjuvant chemotherapy or chemoradiation in patients with resected pancreatic adenocarcinoma by Khattab, Ahmed, Patruni, Sunita, Abel, Stephen, Hasan, Shaakir, Ludmir, Ethan B, Finley, Gene, Monga, Dulabh, Wegner, Rodney E, Verma, Vivek

“…Response of pancreatic adenocarcinoma to neoadjuvant chemotherapy (nCT) or chemoradiotherapy (nCRT) may be associated with prognosis, but long-term outcomes…”
Get full text